Gyre Therapeutics, Inc. GYRE Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s net income?
- Gyre Therapeutics, Inc. (GYRE) reported net income of -$8.69M in Q1 2026.
- How has Gyre Therapeutics, Inc.'s net income changed year-over-year?
- Gyre Therapeutics, Inc.'s net income decreased by 422.1% year-over-year, from $2.7M to -$8.69M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s net income?
- Over 3 years (2021 to 2024), Gyre Therapeutics, Inc.'s net income has grown at a -48.3% compound annual growth rate (CAGR), from -$87.93M to $12.18M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.